youngbaldie
Established Member
- Reaction score
- 3
http://phx.corporate-ir.net/phoenix.zht ... highlight=
Apparently, the topically administered drug proposed by Curis had a "poor safety profile".
This is another major blow to the hedgehog after failing in treating Basal Cell Carcinoma as well.
As far as Curis coming out with a drug that would treat male pattern baldness, that program is now officially over.
Apparently, the topically administered drug proposed by Curis had a "poor safety profile".
This is another major blow to the hedgehog after failing in treating Basal Cell Carcinoma as well.
As far as Curis coming out with a drug that would treat male pattern baldness, that program is now officially over.